Evidence map›Paper›PMID 26221031›Full record

ArticleThe Journal of biological chemistry2015

FANCD2-associated nuclease 1, but not exonuclease 1 or flap endonuclease 1, is able to unhook DNA interstrand cross-links in vitro.

Julia Pizzolato, Shivam Mukherjee, Orlando D Schärer, Josef Jiricny

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Emerging drivers of DNA repeat expansions.Biochemical Society transactions · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Multifaceted Fanconi Anemia Signaling.Trends in genetics : TIG · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Julia PizzolatoFrom the Institute of Molecular Cancer Research, University of Zurich and.
Shivam Mukherjeethe Departments of Chemistry and.
Orlando D Schärerthe Departments of Chemistry and Pharmacological Sciences, Stony Brook University, Stony Brook, New York 11794-3400.
Josef JiricnyFrom the Institute of Molecular Cancer Research, University of Zurich and the Department of Biology, Swiss Institute of Technology (ETH) Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland, and jiricny@imcr.uzh.ch.

Funding

Synthesis, Structure and Repair of DNA Interstrand CrosslinksR01CA165911 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI SCHARER, ORLANDO D. · 2012 to 2016
$1.6M
NCI NIH HHS R01 CA165911
6 · The paper itself

Abstract

Cisplatin and its derivatives, nitrogen mustards and mitomycin C, are used widely in cancer chemotherapy. Their efficacy is linked primarily to their ability to generate DNA interstrand cross-links (ICLs), which effectively block the progression of transcription and replication machineries. Release of this block, referred to as unhooking, has been postulated to require endonucleases that incise one strand of the duplex on either side of the ICL. Here we investigated how the 5' flap nucleases FANCD2-associated nuclease 1 (FAN1), exonuclease 1 (EXO1), and flap endonuclease 1 (FEN1) process a substrate reminiscent of a replication fork arrested at an ICL. We now show that EXO1 and FEN1 cleaved the substrate at the boundary between the single-stranded 5' flap and the duplex, whereas FAN1 incised it three to four nucleotides in the double-stranded region. This affected the outcome of processing of a substrate containing a nitrogen mustard-like ICL two nucleotides in the duplex region because FAN1, unlike EXO1 and FEN1, incised the substrate predominantly beyond the ICL and, therefore, failed to release the 5' flap. We also show that FAN1 was able to degrade a linear ICL substrate. This ability of FAN1 to traverse ICLs in DNA could help to elucidate its biological function, which is currently unknown.

Indexed as

Cell LineDNADNA Repair EnzymesEndodeoxyribonucleasesExodeoxyribonucleasesFlap EndonucleasesHumansMultifunctional EnzymesSubstrate SpecificityDNADNA Repair EnzymesEndodeoxyribonucleasesEXO1 protein, humanExodeoxyribonucleasesFAN1 protein, humanFEN1 protein, humanFlap EndonucleasesMultifunctional EnzymesDNA damageDNA endonucleaseDNA-protein interactionDNA repairenzyme mechanismexonucleaseinterstrand cross-links

Identifiers

PMID26221031
PMCPMC4566234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.